Canopy Growth Corporation

NASDAQ:CGC

Drug Manufacturers - Specialty & Generic

Healthcare
$0.50 +1.07%

+$0.01 today

Market cap
$212.31M
Beta
0.78
P/E (TTM)
-1.8
EPS (TTM)
-$0.76
52W Low $0.84High $2.38

Volume 3.44M

Average 9.97M

CGC Total Non-current Liabilities

All obligations due after more than one year.

Canopy Growth CorporationNASDAQ: CGC

Total Non-current Liabilities · Q4 FY2025 · quarter ended Mar 2026

Total non-current liabilities falls 21.8% from a year ago

Total non-current liabilities stood at CA$262.7M at the end of Q4 FY2025, down 21.8% from a year earlier and down 23.3% from the prior quarter. Over 3 fiscal years it compounded at -25.2% a year.

Context

  • Total non-current liabilities amounted to 23.5% of total assets at the end of Q4 FY2025, down 13.1 pp from a year earlier.
  • Total non-current liabilities increased in 1 of the last 3 fiscal years.

What to watch

Whether total non-current liabilities keeps falling in the next quarterly balance sheet after a -21.8% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
CA$262.7M-23.3% QoQ
Last fiscal yearMar 2026
CA$366.35M+9.0% YoY
Year agoMar 2025
CA$336.08M-21.8% since
Total Non-current Liabilities past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-21.8%——
1 year+9.0%——
3-year CAGR-25.2%——
5-year CAGR——
10-year CAGR——

Total Non-current Liabilities history

CAD · from the balance sheet

Latest · FY2025
366.35M CAD
Year-over-year change
+9.0%
4-year CAGR
-32.6%

Total Non-current Liabilities vs competitors

How CGC compares with its peers on the latest reported figures

  • Peers report in different currencies, so total non-current liabilities is compared through growth and share of total assets rather than absolute size.
  • Its year-over-year change of -21.8% is the 4th highest of 9, against a peer median of -27.6%.
  • Total non-current liabilities amounts to 23.5% of total assets for CGC, versus a peer median of 13.9%.
CGC Competitors
Total Non-current Liabilities for CGC and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
IRWDIronwood Pharmaceuticals, Inc.Mar 2026$415.4M USD-32.3%-0.5%95.6%
CGCCanopy Growth CorporationMar 2026CA$262.7M CAD-21.8%-25.2%23.5%
LFCRLifecore Biomedical, Inc.Dec 2025$222.81M USD——96.0%
DHDefinitive Healthcare Corp.Mar 2026$183.64M USD-15.2%-26.4%35.7%
LYELLyell Immunopharma, Inc.Mar 2026$40.01M USD-23.0%-14.2%11.4%
ACRSAclaris Therapeutics, Inc.Mar 2026$27.7M USD-14.8%-6.4%13.9%
TKNOAlpha Teknova, Inc.Mar 2026$26.84M USD-5.3%-13.1%27.2%
ACBAurora Cannabis Inc.Mar 2026CA$22.38M CAD-83.1%-48.8%3.7%
CABACabaletta Bio, Inc.Mar 2026$3.33M USD-65.3%-0.9%2.3%
BIOABioAge Labs, Inc.Mar 2026$2.71M USD-61.0%-72.9%0.7%
Peer median (excluding CGC) —-27.6%-13.6%13.9%

Competitors are the stored peer set for CGC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

CAD
Metric
FY2021
Mar 2022
FY2022
Mar 2023
FY2023
Mar 2024
FY2024
Mar 2025
FY2025
Mar 2026
Cash & Equivalents776.01M667.69M170.3M113.81M508.58M
Short-term Investments595.65M105.53M33.16M17.66M5.06M
Net Receivables86.58M68.46M51.85M52.78M36.29M
Inventory204.54M83.23M77.29M96.37M154.12M
Other Current Assets31.28M138.17M29.59M8.44M39.39M
Total Current Assets1.73B1.08B371.18M294.57M738.38M
Property, Plant & Equipment (Net)942.78M471.27M320.1M293.52M441.37M
Goodwill1.87B85.56M43.24M46.04M77.66M
Intangible Assets252.7M160.75M104.05M87.2M128.87M
Long-term Investments341.73M568.29M136.22M35.29M150.63M
Tax Assets00000
Other Non-current Assets473.94M76.57M325.53M161.07M23.24M
Total Non-current Assets3.88B1.36B929.15M623.13M821.77M
Total Assets5.61B2.44B1.3B917.7M1.56B
Account Payables64.27M31.84M28.67M26.1M34.82M
Short-term Debt9.3M556.89M103.94M4.26M22.64M
Tax Payables7.14M5.73M10.52M13.07M0
Deferred Revenue005.85M00
Other Current Liabilities76.71M175M53.77M31.73M134.77M
Total Current Liabilities213.19M803.84M234.72M94.4M220.96M
Long-term Debt1.49B749.99M493.29M299.81M302.79M
Deferred Tax Liabilities15.99M357K0011.43M
Deferred Revenue (Non-current)00000
Other Non-current Liabilities162.84M47.12M16.22M8.49M6.35M
Total Non-current Liabilities1.77B875.83M565.11M336.08M366.35M
Total Liabilities1.98B1.68B799.82M430.49M587.31M
Common Stock7.48B7.94B8.24B8.8B9.23B
Retained Earnings(6.38B)(9.67B)(10.33B)(10.93B)(11.14B)
Accumulated OCI(42.28M)(13.86M)(16.05M)535K10.53M
Other Stockholders Equity00000
Minority Interest36.84M1.59M139K00
Total Equity3.62B760.02M500.51M487.21M972.84M
Total Debt1.64B1.41B668M348.4M325.44M
Net Debt864.15M745.98M497.7M234.59M(183.14M)

Canopy Growth Corporation

NASDAQ:CGC

Intrinsic Alpha fair value

Locked

Current Price

$0.50

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.